{"product_id":"bladder-cancer-diagnosis-and-clinical-management-hardback-9781118674840","title":"Bladder Cancer; Diagnosis and Clinical Management (Hardback) 9781118674840","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eBladder Cancer\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eDiagnosis and Clinical Management\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eSeth P. Lerner (Edited by), S Lerner (Author), Mark P. Schoenberg (Edited by), Cora N. Sternberg (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781118674840, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 9 October 2015\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e448 pages\u003cbr\u003e25.2 x 19.6 x 2.3 cm, 1.034 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eB\u003c\/i\u003e\u003ci\u003eladder Cancer: Diagnosis and Clinical Management\u003c\/i\u003e is a 100% clinically-focused guide to bladder cancer, providing practical, modern and evidence-based guidance to the latest in diagnosis and management of the condition. It differs from other books in its complete clinical focus as opposed to a heavy analysis of pathogenesis or basic science.  As a result, practicing urologists and oncologists in the clinical setting will find it an essential resource to consult. \u003c\/p\u003e \u003cp\u003eIn addition to the latest in diagnostic tools and imaging methods, core focus is on the management of each form of cancer at its various stages with up to date genomic data and targeted therapies.  Both drug therapies and the range of surgical options are covered, ensuring that this is the perfect tool for clinicians to consult when considering which type of management program is appropriate for each individual patient.  A key addition is the final section dedicated to optimizing health care delivery, featuring chapters on highly topical issues such as quality of life, patient advocacy and surgical education.\u003c\/p\u003e \u003cp\u003eFull color throughout, and packed with excellent images, each chapter contains concise and didactic practical tips and tricks to enrich the reading experience, in addition to management algorithms and the very latest guidelines from the ASCO, AUA, ESMO and EAU concerning clinical management of bladder cancer.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eList of contributors vii\u003c\/p\u003e \u003cp\u003ePreface xii\u003c\/p\u003e \u003cp\u003eAcknowledgments xiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I: Diagnosis and treatment of non-muscle-invasive bladder cancer\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Pathology 3\u003cbr\u003e\u003ci\u003eHikmat Al-Ahmadie and Donna E. Hansel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Risk stratification of high]grade Ta CIS and T1 urothelial carcinoma of the bladder 18\u003cbr\u003e\u003ci\u003eTobias Klatte, Fred Witjes, Gary Steinberg, and Shahrokh F. Shariat\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Utility of urine biomarkers 26\u003cbr\u003e\u003ci\u003eDerya Tilki and Alexandre R. Zlotta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Novel endoscopic techniques for the detection of bladder cancer 39\u003cbr\u003e\u003ci\u003eAyman Soubra, Joseph C. Liao, and Badrinath Konety\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Transurethral resection of bladder tumors 51\u003cbr\u003e\u003ci\u003eJen-Jane Liu and Mark P. Schoenberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Intravesical chemotherapy 64\u003cbr\u003e\u003ci\u003eLevent N. Türkeri, M.Guillaume Wientjes, and Jessie L.S. Au\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Intravesical immunotherapy 76\u003cbr\u003e\u003ci\u003eNilay M. Gandhi, Laura A. Bertrand, Donald L. Lamm, and Michael A. O’Donnell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 HGT1 bladder cancer: Diagnosis and treatment 89\u003cbr\u003e\u003ci\u003eJ.M. Gaya, J. Palou, and Edward M. Messing\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 What to do when bacillus Calmette-Guérin fails 98\u003cbr\u003e\u003ci\u003eMassimiliano Spaliviero, Guido Dalbagni, and Matthew Nielsen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II: T2–4\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10 Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction 111\u003cbr\u003e\u003ci\u003eRobert S. Svatek and Alon Z. Weizer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Radical cystectomy: Techniques and outcomes 127\u003cbr\u003e\u003ci\u003eSiamak Daneshmand and Seth P. Lerner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Cystectomy in the female patient 144\u003cbr\u003e\u003ci\u003eRyan Werntz, Georgios Gakis, Theresa Koppie, and Arnulf Stenzl\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Laparoscopic\/robotic radical cystectomy and urinary diversion: Outcomes 156\u003cbr\u003e\u003ci\u003eKristina Wittig, Kevin Chan, Mark Kawachi, and Timothy G. Wilson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Robotic assisted radical cystectomy and urinary diversion: Clinical trials 167\u003cbr\u003e\u003ci\u003eGeorge J.S. Kallingal, Angela B. Smith, Raj S. Pruthi, and Dipen J. Parekh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Role of extended lymphadenectomy 176\u003cbr\u003e\u003ci\u003eEugene K. Cha, George N. Thalmann, and Bernard H. Bochner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Management of the urethra in the cystectomy patient 184\u003cbr\u003e\u003ci\u003eKamal S. Pohar and Norm D. Smith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 The role of radical cystectomy in patients with unresectable or regionally metastatic urothelial carcinoma of the bladder 190\u003cbr\u003e\u003ci\u003eScott Delacroix Jr, Nathan Lawrentschuk, and Ashish M. Kamat\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III: Primary bladder-sparing therapy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e18 Radical transurethral resection 201\u003cbr\u003e\u003ci\u003eEduardo Solsona and Harry W. Herr\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Partial cystectomy 212\u003cbr\u003e\u003ci\u003eAhmed Haddad, Yair Lotan, and Arthur I. Sagalowsky\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Integrating chemotherapy and radiotherapy for bladder cancer 221\u003cbr\u003e\u003ci\u003eLior Z. Braunstein, William U. Shipley, Nicholas D. James, Andrea B. Apolo, and Jason A. Efstathiou\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV: Urinary tract reconstruction\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e21 Orthotopic neobladder 235\u003cbr\u003e\u003ci\u003eEila C. Skinner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Continent cutaneous diversion 244\u003cbr\u003e\u003ci\u003eAndreas Neisius and Joachim W. Thüroff\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Non]continent urinary diversion 258\u003cbr\u003e\u003ci\u003eMichael Rink, Fredrik Liedberg, and Margit Fisch\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V: Treatment of regionally advanced and metastatic bladder cancer\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e24 Molecular determinants of chemotherapy response 273\u003cbr\u003e\u003ci\u003eMatthew I. Milowsky, Peter H. O’Donnell, Thomas W. Flaig, and Dan Theodorescu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer 284\u003cbr\u003e\u003ci\u003eDavid I. Quinn and Cora N. Sternberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Adjuvant chemotherapy for invasive bladder cancer 295\u003cbr\u003e\u003ci\u003eAndré P. Fay, Jeffrey J. Leow, and Joaquim Bellmunt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Treatment of metastatic bladder cancer 304\u003cbr\u003e\u003ci\u003eGopa Iyer, Fabio Calabró, and Dean F. Bajorin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Treatment of poor risk patients 320\u003cbr\u003e\u003ci\u003eMaria De Santis and Matthew D. Galsky\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VI: Genomics and the current status of urothelial cancer\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e29 Molecular events in muscle]invasive bladder cancer development 329\u003cbr\u003e\u003ci\u003eJonathan Rosenberg, William Y. Kim, Jaegil Kim, and David J. Kwiatkowski\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Cancer stem cells and intrinsic subtypes in bladder cancer 342\u003cbr\u003e\u003ci\u003eKeith Syson Chan and David J. McConkey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 Multi-targeted agents in the treatment of urothelial carcinoma 353\u003cbr\u003e\u003ci\u003eNoah M. Hahn, Colin P.N. Dinney, and Guru Sonpavde\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VII: Optimizing healthcare delivery\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e32 Patient navigation and cancer navigator programs 365\u003cbr\u003e\u003ci\u003eScott M. Gilbert and Michael Porter\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Impact of health services on compliance and outcomes 375\u003cbr\u003e\u003ci\u003eHeather Honoré Goltz, Marc A. Kowalkowski, G. John Chen, and David M. Latini\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Quality of life and survivorship 384\u003cbr\u003e\u003ci\u003eNihal E. Mohamed and Cheryl T. Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Bladder cancer: Healthcare delivery and third party payers 395\u003cbr\u003e\u003ci\u003eSeth A. Strope and John L. Gore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Bladder cancer patient advocacy: Creating partnerships to advance patient care research and clinical trials 402\u003cbr\u003e\u003ci\u003eDiane Zipursky Quale and Rick Bangs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 409\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Other branches of medicine [\u003ca title=\"See our other books on Other branches of medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Other%20branches%20of%20medicine%20%5BMM%5D%22\"\u003eMM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Brand New","offer_id":52421360058648,"sku":"9781118674840","price":98.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9781118674840.jpg?v=1784592100","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/bladder-cancer-diagnosis-and-clinical-management-hardback-9781118674840","provider":"Freshly Printed Books","version":"1.0","type":"link"}